Meeder Asset Management’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-2,299
| Closed | -$26K | – | 2450 |
|
|
2020
Q2 | $26K | Sell |
2,299
-69
| -3% | -$780 | ﹤0.01% | 1079 |
|
|
2020
Q1 | $32K | Buy |
+2,368
| New | +$32K | ﹤0.01% | 1072 |
|
|
2019
Q4 | – | Sell |
-1,131
| Closed | -$7K | – | 2464 |
|
|
2019
Q3 | $7K | Buy |
1,131
+889
| +367% | +$5.5K | ﹤0.01% | 1671 |
|
|
2019
Q2 | $2K | Buy |
242
+44
| +22% | +$364 | ﹤0.01% | 1897 |
|
|
2019
Q1 | $4K | Sell |
198
-27
| -12% | -$545 | ﹤0.01% | 1461 |
|
|
2018
Q4 | $3K | Buy |
225
+54
| +32% | +$720 | ﹤0.01% | 1537 |
|
|
2018
Q3 | $6K | Buy |
+171
| New | +$6K | ﹤0.01% | 1305 |
|
|
2018
Q1 | – | Sell |
-26
| Closed | -$1K | – | 1793 |
|
|
2017
Q4 | $1K | Sell |
26
-21
| -45% | -$808 | ﹤0.01% | 1612 |
|
|
2017
Q3 | $3K | Sell |
47
-161
| -77% | -$10.3K | ﹤0.01% | 1401 |
|
|
2017
Q2 | $12K | Sell |
208
-368
| -64% | -$21.2K | ﹤0.01% | 963 |
|
|
2017
Q1 | $31K | Buy |
576
+368
| +177% | +$19.8K | ﹤0.01% | 669 |
|
|
2016
Q4 | $12K | Buy |
+208
| New | +$12K | ﹤0.01% | 730 |
|